E. Anitua, C. Pascual, R. Perez-gonzalez, G. Orive, and E. Carro, Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-kappaB-dependent inflammation process in a mouse model of Parkinson's disease, J Control Release, vol.203, pp.170-80, 2015.

E. Anitua, C. Pascual, R. Perez-gonzalez, D. Antequera, S. Padilla et al., Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease, PLoS One, vol.8, issue.9, p.73118, 2013.

M. L. Chou, J. W. Wu, F. Gouel, A. Jonneaux, K. Timmerman et al., Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease, Biomaterials, vol.142, pp.77-89, 2017.

F. Gouel, A. S. Rolland, J. C. Devedjian, T. Burnouf, and D. Devos, Past and future of Neurotrophic growth factors therapies in ALS: from single Neurotrophic growth factor to stem cells and human platelet lysates, Front Neurol, vol.10, p.835, 2019.

O. Leiter and T. L. Walker, Platelets: the missing link between the blood and brain? Progress in neurobiology:101695, 2019.

S. Santos, O. E. Sigurjonsson, C. A. Custodio, and J. Mano, Blood plasma derivatives for tissue engineering and regenerative medicine therapies, Tissue Eng B Rev, vol.24, issue.6, pp.454-62, 2018.

F. Gouel, D. Van, B. Chou, M. L. Jonneaux, A. Moreau et al., The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways, J Tissue Eng Regen Med, vol.11, issue.11, pp.3236-3276, 2017.

Y. Hayon, O. Dashevsky, E. Shai, D. Varon, and R. R. Leker, Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke, Thromb Haemost, vol.110, issue.2, pp.323-353, 2013.

G. Xiong, N. Lingampalli, J. Koltsov, L. L. Leung, N. Bhutani et al., Men and women differ in the biochemical composition of plateletrich plasma, Am J Sports Med, vol.46, issue.2, pp.409-428, 2018.

J. R. Evanson, M. K. Guyton, D. L. Oliver, J. M. Hire, R. L. Topolski et al., Gender and age differences in growth factor concentrations from platelet-rich plasma in adults, Mil Med, vol.179, issue.7, pp.799-805, 2014.

M. Lommatzsch, D. Zingler, K. Schuhbaeck, K. Schloetcke, C. Zingler et al., The impact of age, weight and gender on BDNF levels in human platelets and plasma, Neurobiol Aging, vol.26, issue.1, pp.115-138, 2005.

T. Burnouf, D. Strunk, M. B. Koh, and K. Schallmoser, Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?, Biomaterials, vol.76, pp.371-87, 2016.

T. Burnouf, Modern plasma fractionation, Transfus Med Rev, vol.21, issue.2, pp.101-118, 2007.

T. R. Kreil, Building blocks of the viral safety margins of industrial plasma products, Annals of Blood, vol.3, issue.2, 2018.

J. Irsch and L. Lin, Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system?, Transfus Med Hemother, vol.38, issue.1, pp.19-31, 2011.

S. Ohlsson, B. Diedrich, M. Uhlin, and P. Sandgren, Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage, Vox Sang, vol.113, issue.7, pp.611-632, 2018.

J. Kaiser-guignard, G. Canellini, N. Lion, M. Abonnenc, J. Osselaer et al., The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates, Blood Rev, vol.28, issue.6, pp.235-276, 2014.

H. B. Feys, B. Van-aelst, and V. Compernolle, Biomolecular consequences of platelet pathogen inactivation methods, Transfus Med Rev, vol.33, issue.1, pp.29-34, 2019.

S. Jonsdottir-buch, H. Sigurgrimsdottir, R. Lieder, and O. Sigurjonsson, Expired pathogen inactivated platelet concentrates support differentiation and immunomodulation of mesenchymal stromal cells in culture, J Tissue Eng Regen Med, vol.8, p.374, 2014.

R. Fazzina, P. Iudicone, A. Mariotti, D. Fioravanti, A. Procoli et al., Culture of human cell lines by a pathogeninactivated human platelet lysate, Cytotechnology, vol.68, issue.4, pp.1185-95, 2016.

S. M. Jonsdottir-buch, H. Sigurgrimsdottir, R. Lieder, and O. E. Sigurjonsson, Expired and pathogen-inactivated platelet concentrates support differentiation and immunomodulation of Mesenchymal stromal cells in culture, Cell Transplant, vol.24, issue.8, pp.1545-54, 2015.

T. Burnouf, C. Chang, Y. Kuo, Y. Wu, Y. Tseng et al., A chromatographically purified human TGF-?1 fraction from virally inactivated platelet lysates, Vox Sang, vol.101, issue.3, pp.215-235, 2011.

T. Burnouf, Y. Kuo, D. Blum, S. Burnouf, and C. Su, Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor, Transfusion, vol.52, issue.8, pp.1721-1729, 2012.

M. S. Chen, T. J. Wang, H. C. Lin, and T. Burnouf, Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells, New Biotechnol, vol.49, pp.151-60, 2019.

L. Giliberto, R. Borghi, A. Piccini, R. Mangerini, S. Sorbi et al., Mutant presenilin 1 increases the expression and activity of BACE1, J Biol Chem, vol.284, issue.14, pp.9027-9065, 2009.

V. Vingtdeux, L. Giliberto, H. Zhao, P. Chandakkar, Q. Wu et al., AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism, J Biol Chem, vol.285, issue.12, pp.9100-9113, 2010.

M. Domise, F. Sauvé, S. Didier, R. Caillerez, S. Bégard et al., Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02348480

D. Van, B. Gouel, F. Jonneaux, A. Timmerman, K. Gele et al., Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC, Neurobiol Dis, vol.94, pp.169-78, 2016.

R. Henschler, C. Gabriel, K. Schallmoser, T. Burnouf, and M. Koh, Human platelet lysate current standards and future developments, Transfusion, vol.59, issue.4, pp.1407-1420, 2019.

V. Ciaravino, T. Mccullough, and G. Cimino, The role of toxicology assessment in transfusion medicine, Transfusion, vol.43, issue.10, pp.1481-92, 2003.

P. Sandgren, Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light, Blood Transfus, vol.16, issue.1, pp.118-138, 2018.

G. Harris, H. Hogberg, T. Hartung, and L. Smirnova, 3D differentiation of LUHMES cell line to study recovery and delayed neurotoxic effects, Curr Protoc Toxicol, vol.73, issue.1, pp.11-23, 2017.

L. Oliveira, L. J. Falomir-lockhart, M. G. Botelho, K. H. Lin, P. Wales et al., Elevated ?-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells, Cell Death Dis, vol.6, issue.11, p.1994, 2015.

D. Scholz, D. Poltl, A. Genewsky, M. Weng, T. Waldmann et al., Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line, J Neurochem, vol.119, issue.5, pp.957-71, 2011.

Z. Tong, H. Hogberg, D. Kuo, S. Sakamuru, M. Xia et al., Characterization of three human cell line models for highthroughput neuronal cytotoxicity screening, J Appl Toxicol, vol.37, issue.2, pp.167-80, 2017.

F. Agostini, J. Polesel, M. Battiston, E. Lombardi, S. Zanolin et al., Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approach, J Transl Med, vol.15, issue.1, p.107, 2017.

H. S. Cho, I. H. Song, S. Park, M. C. Sung, M. Ahn et al., Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells, Korean J Lab Med, vol.31, issue.3, pp.212-220, 2011.

S. Habtemariam, The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs, Neural Regen Res, vol.13, issue.6, pp.983-987, 2018.

M. C. Phipps, Y. Xu, and S. L. Bellis, Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds, PLoS One, vol.7, issue.7, p.40831, 2012.

H. Zhao, A. Alam, C. Y. San, S. Eguchi, Q. Chen et al., Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: recent developments, Brain Res, vol.1665, pp.1-21, 2017.

K. M. Kniewallner, N. Grimm, and C. Humpel, Platelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slices, Neurosci Lett, vol.574, pp.64-73, 2014.

O. Leiter, S. Seidemann, R. W. Overall, B. Ramasz, N. Rund et al., Exercise-induced activated platelets increase adult hippocampal precursor proliferation and promote neuronal differentiation, Stem Cell Rep, vol.12, issue.4, pp.667-79, 2019.

A. N. Boing, E. Van-der-pol, A. E. Grootemaat, F. A. Coumans, A. Sturk et al., Single-step isolation of extracellular vesicles by size-exclusion chromatography, J Extracell Vesicles, vol.3, 2014.

I. B. Copland, M. A. Garcia, E. K. Waller, J. D. Roback, and J. Galipeau, The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy, Biomaterials, vol.34, issue.32, pp.7840-50, 2013.

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev et al., Ferroptosis: an Iron-dependent form of nonapoptotic cell death, Cell, vol.149, issue.5, pp.1060-72, 2012.

S. Doll, B. Proneth, Y. Y. Tyurina, E. Panzilius, S. Kobayashi et al., ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition, Nat Chem Biol, vol.13, p.91, 2016.

J. Lotharius, J. Falsig, J. Van-beek, S. Payne, R. Dringen et al., Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway, J Neurosci, vol.25, issue.27, pp.6329-6371, 2005.

S. J. Dixon, G. E. Winter, L. S. Musavi, E. D. Lee, B. Snijder et al., Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death, ACS Chem Biol, vol.10, issue.7, pp.1604-1613, 2015.

S. J. Guiney, P. A. Adlard, A. I. Bush, D. I. Finkelstein, and S. Ayton, Ferroptosis and cell death mechanisms in Parkinson's disease, Neurochem Int, vol.104, pp.34-48, 2017.

M. Gawaz and S. Vogel, Platelets in tissue repair: control of apoptosis and interactions with regenerative cells, Blood, vol.122, issue.15, pp.2550-2554, 2013.

S. M. Jonsdottir-buch, R. Lieder, and O. E. Sigurjonsson, Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells, PLoS One, vol.8, issue.7, p.68984, 2013.

L. Barro, Y. Su, O. Nebie, Y. W. Wu, Y. H. Huang et al., A double virally-inactivated (intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells transfusion, vol.59, pp.2061-73, 2019.

K. Bieback, A. Hecker, A. Kocaomer, H. Lannert, K. Schallmoser et al., Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow, Stem Cells, vol.27, issue.9, pp.2331-2372, 2009.

T. Burnouf and M. Radosevich, Reducing the risk of infection from plasma products: specific preventative strategies, Blood Rev, vol.14, issue.2, pp.94-110, 2000.

S. D. Keil, A. Bengrine, R. Bowen, S. Marschner, N. Hovenga et al., Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment, Transfusion, vol.55, issue.7, pp.1736-1780, 2015.

U. Gravemann, W. Handke, B. Lambrecht, J. P. Schmidt, T. H. Muller et al., Ultraviolet C light efficiently inactivates nonenveloped hepatitis a virus and feline calicivirus in platelet concentrates, Transfusion, vol.58, issue.11, pp.2669-74, 2018.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations